the endpoints compared were body-weight gain , longevity , visible and palpable swellings , absolute and relative organ weights , microscopically confirmed malignant neoplasms that contributed to death before the end of the study at 2 yr , incidence of other neoplasms in decedents and rats killed at the end of the study , and the incidence of various non-neoplastic conditions including myocardial inflammation and fibrosis , chronic progressive nephropathy , liver glycogen storage and fatty degeneration , mammary gland hyperplasia and secretory activity , pancreatic polyarteritis , radiculoneuropathy and certain testicular changes .
C0006826
malignant neoplasms
C0027651
neoplasms